about
Inhibitor development and substitution therapy in a developing country: Turkey.Zero incidence of inhibitor development in previously treated haemophilia A, HIV-negative patients upon exposure to a plasma-derived high-purity and double viral inactivated factor VIII concentrate.Major surgery for a gastric cancer in a haemophilic with high inhibitor titre successfully performed by the use of recombinant FVIIa.Development of inhibitors in patients with haemophilia from India.
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Inhibitors of factor VIII and IX.
@en
Inhibitors of factor VIII and IX.
@nl
type
label
Inhibitors of factor VIII and IX.
@en
Inhibitors of factor VIII and IX.
@nl
prefLabel
Inhibitors of factor VIII and IX.
@en
Inhibitors of factor VIII and IX.
@nl
P2860
P1433
P1476
Inhibitors of factor VIII and IX.
@en
P2093
D B Brettler
P2860
P356
10.1111/J.1365-2516.1995.TB00108.X
P478
P577
1995-01-01T00:00:00Z